Newport Corporation announced the acquisition of FEMTOLASERS Produktions GmbH, a leading developer and manufacturer of ultrafast laser systems used extensively in scientific and biomedical research applications. Widely recognized for developing the world's highest precision ultrafast lasers, FEMTOLASERS enables some of the most advanced research applications, including the pioneering of attosecond (10-18 second) science to study physical, chemical and biological phenomena at the atomic and subatomic levels. Established in 1994, FEMTOLASERS is headquartered in Vienna, Austria and has an installed base of more than 850 systems in over 30 countries.https://cdn.specpick.com/newport.jpg712370
"We are excited to announce our agreement to acquire FEMTOLASERS, which will advance our strategic initiative to extend our industry leadership in ultrafast lasers," said David Allen, Senior Vice President and General Manager of Newport's Spectra-Physics Lasers Group. "FEMTOLASERS has developed some truly impressive leading-edge technology that will be invaluable as we work together to develop the next generation of ultrafast lasers. We welcome the FEMTOLASERS team to Newport and look forward to their contributions to our Spectra-Physics Lasers Group."
The terms of the transaction were not disclosed however Newport expects FEMTOLASERS sales to be in the range of $8 million to $12 million in the first 12 Months. The transaction is expected to close during the first quarter of 2015.
